Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $1,091,805.75 in Stock

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 23,107 shares of the firm's stock in a transaction on Monday, June 23rd. The stock was sold at an average price of $47.25, for a total value of $1,091,805.75. Following the completion of the transaction, the chief financial officer now owns 63,222 shares in the company, valued at approximately $2,987,239.50. This trade represents a 26.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Oluyemi Okupe also recently made the following trade(s):

• On Wednesday, May 28th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The stock was sold at an average price of $52.98, for a total transaction of $613,561.38.
• On Thursday, May 15th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The shares were sold at an average price of $60.22, for a total transaction of $697,407.82.
• On Tuesday, April 15th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The stock was sold at an average price of $28.50, for a total value of $330,058.50.
• On Wednesday, April 2nd, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The stock was sold at an average price of $29.26, for a total transaction of $338,860.06.

Hims & Hers Health Stock Performance

Shares of HIMS traded up $1.00 during trading hours on Tuesday, hitting $42.98. 63,206,502 shares of the stock were exchanged, compared to its average volume of 22,376,816. The stock's 50-day moving average price is $48.71 and its two-hundred day moving average price is $39.33. Hims & Hers Health, Inc. has a 12-month low of $13.47 and a 12-month high of $72.98. The company has a market cap of $9.62 billion, a price-to-earnings ratio of 62.30, a price-to-earnings-growth ratio of 2.42 and a beta of 2.09.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.08. Hims & Hers Health had a net margin of 9.24% and a return on equity of 22.75%. The firm had revenue of $586.01 million for the quarter, compared to the consensus estimate of $535.21 million. During the same period last year, the firm posted $0.05 earnings per share. The company's revenue for the quarter was up 110.7% on a year-over-year basis. On average, research analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on HIMS shares. Bank of America upped their price target on shares of Hims & Hers Health from $22.00 to $26.00 and gave the stock an "underperform" rating in a report on Tuesday, April 29th. UBS Group reissued a "mixed" rating on shares of Hims & Hers Health in a research report on Tuesday, May 6th. Piper Sandler restated a "neutral" rating and set a $39.00 price objective (up previously from $35.00) on shares of Hims & Hers Health in a report on Tuesday, May 6th. Needham & Company LLC reissued a "hold" rating on shares of Hims & Hers Health in a report on Monday. Finally, Leerink Partners raised their target price on shares of Hims & Hers Health from $24.00 to $40.00 and gave the stock a "market perform" rating in a report on Tuesday, February 25th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $38.00.

Institutional Investors Weigh In On Hims & Hers Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Strs Ohio acquired a new position in shares of Hims & Hers Health during the 1st quarter valued at about $1,469,000. Kilter Group LLC raised its stake in Hims & Hers Health by 1.0% during the first quarter. Kilter Group LLC now owns 43,989 shares of the company's stock worth $1,300,000 after purchasing an additional 450 shares during the period. Geneos Wealth Management Inc. acquired a new stake in shares of Hims & Hers Health during the 1st quarter worth approximately $30,000. Intech Investment Management LLC raised its position in shares of Hims & Hers Health by 74.5% during the 1st quarter. Intech Investment Management LLC now owns 143,287 shares of the company's stock valued at $4,234,000 after buying an additional 61,195 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Hims & Hers Health by 23.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 418,699 shares of the company's stock valued at $12,373,000 after acquiring an additional 78,543 shares during the last quarter. Institutional investors and hedge funds own 63.52% of the company's stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.